Approval for Moderna’s mRESVIA is the 1st time an mRNA vaccine has been approved for a disease other than Covid. This could be crucial for India where RSV's a major public health challenge.
Hungarian biochemist Kariko & American immunologist Weismann won for research in mRNA, which enabled vaccine development for Covid. This followed decades of struggle.
Mice treated with the mRNA vaccine, delivered like ones for Covid, showed reduction in tumours & long-term immune memory, says study by Tufts University researchers published in PNAS.
Researchers at University of California San Diego Health find that vaccine efficacy in US health workers dipped from 90% to 65.5%, recommend continued use of masks & intensive testing.
Of the 189 patients who participated in the study, 130 received the Moderna vaccine, while 59 got the Pfizer-BioNTech vaccine. Second dose was administered to 159 subjects.
According to the two studies, there is a link between mRNA-based vaccines and the heart condition myocarditis. But experts caution that the link between the two does not establish causality.
In FY 2025-26, AoN for 55 proposals amounting to Rs 6.73 lakh cr has been accorded by DAC. Both the quantum of AoN given and capital contracts signed, so far, have been the highest in any FY.
COMMENTS